Cargando…
The progression rate of spinocerebellar ataxia type 3 varies with disease stage
BACKGROUND: In polyglutamine (polyQ) diseases, the identification of modifiers and the construction of prediction model for progression facilitate genetic counseling, clinical management and therapeutic interventions. METHODS: Data were derived from the longest longitudinal study, with 642 examinati...
Autores principales: | Peng, Linliu, Peng, Yun, Chen, Zhao, Wang, Chunrong, Long, Zhe, Peng, Huirong, Shi, Yuting, Shen, Lu, Xia, Kun, Leotti, Vanessa B., Jardim, Laura Bannach, Tang, Beisha, Qiu, Rong, Jiang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107762/ https://www.ncbi.nlm.nih.gov/pubmed/35568848 http://dx.doi.org/10.1186/s12967-022-03428-1 |
Ejemplares similares
-
Anxiety and depression in spinocerebellar ataxia patients during the COVID-19 pandemic in China: A cross-sectional study
por: Gong, Yiqing, et al.
Publicado: (2021) -
The progression rate of spinocerebellar ataxia type 2 changes with stage of disease
por: Monte, Thais Lampert, et al.
Publicado: (2018) -
The Natural History of Spinocerebellar Ataxia Type 3 in Mainland China: A 2-Year Cohort Study
por: Peng, Yun, et al.
Publicado: (2022) -
Explainable artificial intelligence based on feature optimization for age at onset prediction of spinocerebellar ataxia type 3
por: Ru, Danlei, et al.
Publicado: (2022) -
RNA Expression Profile and Potential Biomarkers in Patients With Spinocerebellar Ataxia Type 3 From Mainland China
por: Li, Tianjiao, et al.
Publicado: (2019)